Table 3.
Total Sample | CT-as-usual | CT+Memory Support | |||||||
---|---|---|---|---|---|---|---|---|---|
Measures | N | M | SD | N | M | SD | N | M | SD |
Cumulative recall | |||||||||
Session 7 | 40 | 8.20 | 3.90 | 19 | 7.84 | 2.52 | 21 | 8.52 | 4.87 |
post-treatment | 40 | 9.00 | 5.11 | 18 | 7.94 | 3.37 | 22 | 9.86 | 6.13 |
Follow-up | 40 | 8.13 | 4.84 | 19 | 7.58 | 4.59 | 21 | 8.62 | 5.11 |
Past session recall | |||||||||
Session 7 | 40 | 4.65 | 2.77 | 19 | 4.95 | 3.01 | 21 | 4.38 | 2.58 |
post-treatment | 40 | 4.43 | 3.94 | 18 | 3.61 | 3.53 | 22 | 5.09 | 4.21 |
Follow-up | 40 | 3.28 | 3.22 | 19 | 3.11 | 3.31 | 21 | 3.43 | 3.20 |
IDS-SR scores | |||||||||
at baseline | 48 | 41.19 | 9.23 | 23 | 43.00 | 9.77 | 25 | 39.52 | 8.55 |
at post-treatment | 42 | 22.29 | 11.56 | 20 | 25.45 | 10.83 | 22 | 19.41 | 11.69 |
at follow-up | 41 | 23.12 | 13.30 | 20 | 24.60 | 13.70 | 21 | 21.71 | 13.07 |
GAF scores | |||||||||
at baseline | 47 | 59.51 | 4.59 | 22 | 59.45 | 5.47 | 25 | 59.56 | 3.75 |
at post-treatment | 41 | 69.24 | 8.72 | 19 | 66.63 | 8.39 | 22 | 71.50 | 8.55 |
at follow-up | 41 | 70.44 | 11.54 | 20 | 68.80 | 11.98 | 21 | 72.00 | 11.17 |
Note. M = Mean. SD = Standard Deviation.